A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This trial is designed to show the effect of treatment with TT223 or placebo on blood glucose control after 12 weeks of treatment with a 6 month follow-up. TT223 is administered by injection once daily to patients currently treated with Metformin and/or Thiazolidinedione.
Epistemonikos ID: 9e5074c86203408062f71167ba3a6ac9cbefec40
First added on: May 05, 2024